US Patent 11078280 Oncolytic viral delivery of therapeutic polypeptides
Patent 11078280 was granted and assigned to Oncorus on August, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+438 characters)
Article
Patent abstract
Described herein are pseudotyped oncolytic viruses comprising nucleic acids encoding an engager molecule. In some embodiments, the pseudotyped oncolytic viruses comprises nucleic acids encoding an engager molecule and one or more therapeutic molecules. Pharmaceutical compositions containing the pseudotyped oncolytic virus and methods of treating cancer using the pseudotyped oncolytic viruses are further provided herein.
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Luke Evnin0
Mitchell H. Finer0
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 3 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
110782800
Date of Patent
August 3, 2021
0Patent Application Number
202001280
Date Filed
January 28, 2020
0Official Website
Edits on 19 May, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 8 Oct, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 11078280 Oncolytic viral delivery of therapeutic polypeptides
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11078280
Date of patent
August 3, 2021
Patent application number
20200128
Date Filed
January 28, 2020
Find more entities like US Patent 11078280 Oncolytic viral delivery of therapeutic polypeptides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
